Aurora Cannabis (ACB) Gets a Buy from Canaccord Genuity
TipRanks (Thu, 6-Aug 11:01 AM ET)
TipRanks (Thu, 6-Aug 8:40 AM ET)
Aurora Cannabis Q1 2027 Results Highlight Shift to Global Medical Markets and EU-GMP Expansion
TipRanks (Wed, 5-Aug 9:58 AM ET)
Aurora Cannabis gains after Q1 results on outlook
Seeking Alpha News (Wed, 5-Aug 8:46 AM ET)
Aurora Cannabis Files Q1 FY2027 Interim Results with U.S. SEC
TipRanks (Wed, 5-Aug 7:29 AM ET)
Aurora Cannabis reports Q1 results
Seeking Alpha News (Wed, 5-Aug 7:07 AM ET)
Aurora Cannabis Announces Fiscal 2027 First Quarter Results
PRNewswire (Wed, 5-Aug 7:02 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 4-Aug 6:00 PM ET)
Aurora Cannabis Q1 Preview: What to expect
Seeking Alpha News (Tue, 4-Aug 1:18 PM ET)
Earnings Week Ahead: PLTR, AMD, PFE, DIS, SHOP, VTRS, CGC, MCD, ROKU, ABNB, and more
Seeking Alpha News (Sun, 2-Aug 8:07 AM ET)
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of August 6, 2026, ACB stock price climbed to $2.98 with 1,868,662 million shares trading.
ACB has a beta of 1.43, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.13 to the broad based SPY ETF.
ACB has a market cap of $184.59 million. This is considered a Micro Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $49 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.08.
In the last 3 years, ACB traded as high as $11.50 and as low as $2.56.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO, DFIC.
ACB has underperformed the market in the last year with a return of -35.2%, while the SPY ETF gained +23.6%. In the last 3 month period, ACB fell short of the market, returning -13.4%, while SPY returned +6.5%. However, in the most recent 2 weeks ACB has outperformed the stock market by returning +12.0%, while SPY returned +2.8%.
ACB support price is $2.85 and resistance is $2.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.